Uncategorized
Opinion: Ending birthright citizenship could be a public health disaster
Sometime before the end of June, the Supreme Court is expected to deliver its opinion in Trump v. Barbara, the case challenging President Trump’s executive order seeking to end birthright citizenship in the United States. At stake is the long-standing interpretation of the Citizenship Clause of the 14th Amendment, which for more than a century has been understood and affirmed to mean that any child born in the United States, regardless of their parents’ citizenship status, is a U.S. citizen (with a remarkably narrow exception carved out for the children of diplomats).
Ending the guarantee of birthright citizenship would dramatically increase the size of the undocumented population in the U.S. and could invite a future executive to nullify the citizenship of countless American-born children of immigrants. It would also have stark consequences at the intersection of bioethics and public health.
Sometime before the end of June, the Supreme Court is expected to deliver its opinion in Trump v. Barbara, the case challenging President Trump’s executive order seeking to end birthright citizenship in the United States. At stake is the long-standing interpretation of the Citizenship Clause of the 14th Amendment, which for more than a century has been understood and affirmed to mean that any child born in the United States, regardless of their parents’ citizenship status, is a U.S. citizen (with a remarkably narrow exception carved out for the children of diplomats).
Ending the guarantee of birthright citizenship would dramatically increase the size of the undocumented population in the U.S. and could invite a future executive to nullify the citizenship of countless American-born children of immigrants. It would also have stark consequences at the intersection of bioethics and public health.
Uncategorized
STAT+: Biosecure didn’t stop China’s rise in biotech. Some lawmakers want to do more
WASHINGTON — Last year, Congress passed a bill restricting how U.S. pharmaceutical and biotechnology companies can do business with Chinese firms. Many political leaders don’t seem to be satisfied.
Already, they’re laying the groundwork for additional legislative and regulatory measures to counter the rise of Chinese biopharma companies. And federal health officials are working to make it easier for companies to operate in the U.S.
“The itch has not been entirely scratched,” said Bobby McMillin, partner at Arnold Porter.
WASHINGTON — Last year, Congress passed a bill restricting how U.S. pharmaceutical and biotechnology companies can do business with Chinese firms. Many political leaders don’t seem to be satisfied.
Already, they’re laying the groundwork for additional legislative and regulatory measures to counter the rise of Chinese biopharma companies. And federal health officials are working to make it easier for companies to operate in the U.S.
“The itch has not been entirely scratched,” said Bobby McMillin, partner at Arnold Porter.
Recent BioSpace industry conference conversations point to sponsors pushing earlier on safety, quality and performance data, leading to demand for nitrosamine analysis, IVRT/IVPT and microbiome database capabilities.
Uncategorized
10 companies hiring in San Francisco, South San Francisco (plus a few in Brisbane, San Rafael)
10 companies hiring in San Francisco, South San Francisco (plus a few in Brisbane, San Rafael)
Looking for a new role in and around San Francisco? Check out these companies hiring across all disciplines. Read More
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
STAT+: Biosecure didn’t stop China’s rise in biotech. Some lawmakers want to do more
10 companies hiring in San Francisco, South San Francisco (plus a few in Brisbane, San Rafael)
Labs see rising demand for nitrosamine, topical performance and microbiome testing
Drug Targets LDL Receptor Pathway to Control Cholesterol
First-in-Human Stem Cell Therapy Trial for Huntington’s Disease Begins at UCI Health
STAT+: Eli Lilly dives into hair loss treatments with investment in AI startup Absci
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Endpoints News3 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized3 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform